NL-OMON25700招募中不适用
Efficacy of a mouthrinse containing Ardox-X® Technology on the inhibition of de novo dental plaque formation in vivo.
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 入组人数
- 50
研究概览
简要总结
/A
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1. ≥ 18 years;
- •2. Systemically healthy;
排除标准
- •1. The use of antibiotics during the last 6 months;
- •2. Dutch Periodontal Screening Index (DPSI) ≥3+;
研究者
相似试验
已完成
不适用
Efficacy of a mouthrinse containing Ardox-X® Technology on the inhibition of de novo dental plaque formation in vivoTandplakvormingde novo plaque formationNL-OMON35463ACTA dental research B.V.50
已完成
Unknown
Effect of mouthwash on the reduction of salivary SARS-CoV-2JPRN-jRCTs051220107Kutsuna Satoshi95
尚未招募
不适用
Clinical Efficacy of a Chlorhexidine-based Mouth-rinse Containing Citrus Aurantium AmaraWound HealingNCT06738342University of Roma La Sapienza32
进行中（未招募）
1 期
Efficacy of DC071 mouthwash (0,2 % chlorhexidine digluconate) in peri-surgical care for preventing alveolar osteitis after third molar extraction.Prevention of alveolar osteitis after third molar extractionMedDRA version: 18.0 Level: PT Classification code 10066995 Term: Alveolar osteitis System Organ Class: 10021881 - Infections and infestationsEUCTR2014-004682-24-FRPIERRE FABRE MEDICAMENT409
进行中（未招募）
1 期
Efficacy of DC071 mouthwash (0,2 % chlorhexidine digluconate) in peri-surgical care for preventing alveolar osteitis after third molar extraction.EUCTR2014-004682-24-EEInstitut de Recherche Pierre Fabre - Centre de R&D Pierre Fabre414